Valuation Aptose Biosciences Inc. OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 03:55:47 27/06/2026 HKT			5-day change	1st Jan Change
1.550 ^USD	+1.31%		-0.64%	+4.73%

06-15	Aptose Biosciences Inc. Presents Safety, Response and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML	CI
06-15	Aptose Biosciences Updated Tuscany Trial Data Reported in Oral Presentation at EHA 2026	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	389.8	121.6	53.19	20.15	13.59	3.947
Change	-	-68.8%	-56.27%	-62.12%	-32.53%	-70.97%
Enterprise Value (EV) ¹	268.5	43.09	7.535	11.91	18.08	30.22
Change	-	-83.95%	-82.51%	58.06%	51.81%	67.16%
P/E	-6.5x	-1.86x	-1.27x	-0.33x	-0.19x	-0.15x
PBR	3.28x	1.7x	1.41x	-6.94x	-2.99x	-0.15x
PEG	-	-0.21x	0x	-0x	0x	0x
Capitalization / Revenue	-	-	-	-	-	-
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-4.83x	-0.66x	-0.18x	-0.23x	-0.69x	-1.22x
EV / EBIT	-4.81x	-0.66x	-0.18x	-0.23x	-0.69x	-1.22x
EV / FCF	-20.4x	-1.66x	-0.45x	-0.46x	-0.68x	-2.41x
FCF Yield	-4.89%	-60.4%	-220%	-217%	-147%	-41.5%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-303.7	-330.1	-204	-227.4	-36.38	-10.41
Distribution rate	-	-	-	-	-	-
Net sales	-	-	-	-	-	-
EBITDA ¹	-55.62	-65.3	-42.48	-52.27	-26.22	-24.7
EBIT ¹	-55.77	-65.45	-42.6	-52.36	-26.26	-24.72
Net income ¹	-55.24	-65.35	-41.82	-51.21	-25.43	-25.47
Net Debt ¹	-121.3	-78.55	-45.66	-8.237	4.487	26.28
Reference price ²	1,974.181	615.177	259.343	76.100	6.776	1.546
Nbr of stocks (in thousands)	197	198	205	265	2,006	2,552
Announcement Date	23/3/21	22/3/22	24/3/23	26/3/24	28/3/25	31/3/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
ASTRAZENECA PLC	23.72x	4.94x	14x	1.76%	293B
NOVARTIS AG	21.69x	5.59x	13.51x	2.83%	286B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
Average	16.62x	6.50x	16.54x	2.43%	401.79B
Weighted average by Cap.	24.44x	7.95x	18.32x	1.97%